Publication: A general strategy to construct small molecule biosensors in eukaryotes
Open/View Files
Date
2015
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
eLife Sciences Publications, Ltd
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Feng, J., B. W. Jester, C. E. Tinberg, D. J. Mandell, M. S. Antunes, R. Chari, K. J. Morey, et al. 2015. “A general strategy to construct small molecule biosensors in eukaryotes.” eLife 4 (1): e10606. doi:10.7554/eLife.10606. http://dx.doi.org/10.7554/eLife.10606.
Research Data
Abstract
Biosensors for small molecules can be used in applications that range from metabolic engineering to orthogonal control of transcription. Here, we produce biosensors based on a ligand-binding domain (LBD) by using a method that, in principle, can be applied to any target molecule. The LBD is fused to either a fluorescent protein or a transcriptional activator and is destabilized by mutation such that the fusion accumulates only in cells containing the target ligand. We illustrate the power of this method by developing biosensors for digoxin and progesterone. Addition of ligand to yeast, mammalian, or plant cells expressing a biosensor activates transcription with a dynamic range of up to ~100-fold. We use the biosensors to improve the biotransformation of pregnenolone to progesterone in yeast and to regulate CRISPR activity in mammalian cells. This work provides a general methodology to develop biosensors for a broad range of molecules in eukaryotes. DOI: http://dx.doi.org/10.7554/eLife.10606.001
Description
Other Available Sources
Keywords
biosensors, metabolic engineering, CRISPR, <i>A. thaliana</i>, Human, <i>S. cerevisiae</i>
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service